Skip to main content

Table 1 Demographics and baseline characteristics (combined b.i.d. and t.i.d. dosing)

From: A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis

Demographics Placebo (n = 18) GSK2982772 (n = 33)
Age, years (mean [SD])a 53.1 (7.28) 54.8 (10.72)
Sex, n (%)
 Female 15 (83) 27 (82)
 Male 3 (17) 6 (18)
BMI, kg/m2 (mean [SD]) 26.5 (4.35) 27.8 (4.48)
Ethnicity, n (%)
 Hispanic or Latino 0 2 (6)
 Not Hispanic or Latino 18 (100) 31 (94)
Race detail
 American Indian or Alaskan native 0 1 (3)
 White—White/Caucasian/European Heritage 18 (100) 32 (97)
Time since formal diagnosis of RA, years
 Mean (SD) 4.5 (3.27) 7.3 (7.24)
 Median (min, max) 3.9 (0.6, 12.9) 4.4 (0.4, 31.1)
Time since onset of first musculoskeletal symptoms, years
 Mean (SD) 6.6 (4.30) 9.5 (8.44)
 Median (min, max) 5.5 (2.1, 14.4) 7.8 (0.6, 33.1)
Baseline medical conditions, n (%)
 Cardiovascular risk factors 8 (44) 12 (36)
 Other risk factors 11 (61) 19 (58)
Baseline (day 1) DAS28-CRP
 Mean (SD) 5.4 (1.17) 5.2 (0.76)
 Median (min, max)a 5.5 (1.9, 7.2) 5.1 (3.7, 7.1)
Baseline (day 1) CRP
 Mean (SD) 19.8 (15.52) 14.4 (19.47)
 Median (min, max)a 15.1 (1.3, 53.5) 9.4 (0.9, 98.2)
Baseline (day 1) RAMRIS
 Synovitis
  Mean (SD) 6.4 (4.70) 10.5 (4.97)
  Median (min, max) 6.0 (0, 15) 10.0 (2, 20)
 Bone erosion
  Mean (SD) 11.5 (11.02) 16.5 (13.36)
  Median (min, max) 7.0 (1, 40) 16.0 (1, 54)
 Osteitis
  Mean (SD) 5.3 (7.97) 6.4 (9.61)
  Median (min, max) 1.0 (0, 28) 2.0 (0, 36)
Baseline (day 1) CARLOS
 Mean (SD) 4.7 (9.32) 6.0 (9.06)
 Median (min, max) 0 (0, 34) 1.5 (0, 36)
Baseline (day 1) Vectra DA
 Mean (SD) 50.8 (14.85) 50.9 (13.39)
 Median (min, max) 51.5 (21, 69) 49.0 (29, 89)
Baseline (day 1) HAQ-DI
 Mean (SD) 1.3 (0.79) 1.2 (0.61)
 Median (min, max) 1.6 (0.0, 2.3) 1.4 (0.0, 2.1)
Baseline (day 1) FACIT-Fatigue
 Mean (SD) 24.3 (9.92) 32.6 (10.18)
 Median (min, max) 23.5 (8, 50) 32.5 (16, 52)
  1. Data are expressed as mean (SD) unless otherwise stated
  2. aMinimum values are outside the inclusion criteria because minimum values for inclusion were assessed at screening, and these data represent data collected at the baseline visit (day 1)
  3. b.i.d., twice daily; BMI, body mass index; CARLOS, Cartilage Loss Scoring System; CRP, C-reactive protein; DAS28-CRP, disease activity score for 28 joints using CRP value; FACIT, Functional Assessment of Chronic Illness Therapy; HAQ-DI, Health Assessment Questionnaire-Disability Index; RA, rheumatoid arthritis; RAMRIS, Rheumatoid Arthritis MRI Scoring System; SD, standard deviation; t.i.d., three times daily; Vectra DA, Vectra disease activity